Hanna K. Sanoff
Hematology & Oncology · Unc Physicians and Associates
Credentials: · · ·
History
Research
PLoS Genetics · 2010 · 748 citations
Treatment of Metastatic Colorectal Cancer: ASCO Guideline
Systematic review or meta-analysis · Journal of Clinical Oncology · 2023 · 549 citations
Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging
Aging Cell · 2009 · 397 citations
- RG
20 papers
18 papers · 3 as a fellow
18 papers
- GW
14 papers · 7 as a fellow
12 papers · 2 as a fellow
9 papers · 2 as a resident
- AM
8 papers
8 papers
Grants
- 2011–2016
Use and Comparative Effectiveness of Innovative Therapies for Hepatocellular Carc
National Cancer Institute · K07
Contact PI · $850.5K · Univ of North Carolina Chapel Hill
Clinical trials
- 2018–2026
Palbociclib and Cetuximab in Metastatic Colorectal Cancer
Principal investigator · Completed · Phase 2
UNC Lineberger Comprehensive Cancer Center
- 2018–2024
PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC
Principal investigator · Completed · Phase 2
UNC Lineberger Comprehensive Cancer Center
- 2011–2015
Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
Principal investigator · Completed · Phase 2
UNC Lineberger Comprehensive Cancer Center
- 2011–2020
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Principal investigator · Completed · Phase 2
UNC Lineberger Comprehensive Cancer Center